-
First drug to slow Alzheimer’s disease gets full FDA and Medicare approval for early-stage cases; drug is still in clinical trials at UK
BY MELISSA PATRICK KENTUCKY HEALTH NEWS The U.S. Food and Drug Administration has granted full approval for the first drug to slow down the progression of Alzheimer’s disease, opening the door for Medicare to pay for it. “This is the first medicine ever that actually changes the disease in the brain, removes a component of…
Tag: FDA
